Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,647,016
+$5,243,158 QoQ
Shares Held
8,043
+68.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,279
of 4,604 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Frec Markets, Inc. holds $35,342,680 across 14 Drug Manufacturers - General names. LLY ranks #1 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,043 | $9,647,016 | |
| 2 | JNJ |
Johnson & Johnson
|
27,439 | $6,968,682 | |
| 3 | ABBV |
AbbVie Inc.
|
19,777 | $4,976,684 | |
| 4 | MRK |
Merck & Co., Inc.
|
34,217 | $4,396,884 | |
| 5 | AMGN |
Amgen Inc
|
4,619 | $1,672,632 | |
| 6 | AZN |
Astrazeneca PLC
|
6,171 | $1,170,145 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,527 | $1,125,145 | |
| 8 | NVS |
Novartis AG
|
7,133 | $1,117,883 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,647,016 | 8,043 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,403,858 | 4,788 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,268,629 | 3,972 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||